Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (868)	6/2/1998 9:13:00 PM
From: M. Ramle	Read Replies (1) of 10280

Peter: Thanks for the encouraging comment, which is desparately needed to boost the BULLS' moral (at least mine) given today's masacre. Anyway, the following insert was quoted at Yahoo.com chatroom in regards to SEPR's price drop: <<< TORONTO, June 2 /PRNewswire/ -- Wyeth-Ayerst Laboratories, a division of American Home Products Corporation (NYSE: AHP), presented data today at the American Psychiatric Association Annual Meeting in Toronto, Canada, demonstrating that patients with depression who were treated with Effexor(R) XR (venlafaxine HCl) Extended-Release Capsules experienced a statistically significantly higher rate of remission as defined in the study, than patients who were treated with Prozac(R) (fluoxetine). Results from a second study showed that Effexor XR and Prozac had comparable efficacy; however, Effexor XR produced a greater response at specific time points in reducing concomitant anxiety symptoms in patients with depression when compared to Prozac >>>. Your response (and all others) would be greatly appreciated: Mazen.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next